Search research articles
Contact Us
Filters
Showing results (651-660 of 697) with videos related to
Page
of 70
Sort By:
Diabetes, Obesity & Metabolism
|
May 5, 2012
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial
L D Monti, E Setola, P C G Lucotti, et al.
Transplantation Proceedings
|
May 31, 2011
Analysis of the motivation for hematopoietic stem cell donation
M T Aurelio, A Aniasi, S E Haworth, et al.
Human Gene Therapy
|
June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis
P L Poliani, H Brok, R Furlan, et al.
European Journal of Neurology
|
March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study
M S Freedman, G S Francis, E A C M Sanders, et al.
Brain Stimulation
|
December 5, 2013
Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study
F Spagnolo, M A Volonté, M Fichera, et al.
Annals of Hematology
|
January 29, 2017
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma
Novella Pugliese, M Di Perna, I Cozzolino, et al.
Neurology
|
May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MS
M P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology
|
February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a
H Vrenken, M Battaglini, M L de Vos, et al.
Neurology
|
March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS
M Inglese, J H T M van Waesberghe, M Rovaris, et al.
Page
of 70
Search research articles
Search
Showing results (651-660 of 697) with videos related to
Sort By:
Page
of 70
Diabetes, Obesity & Metabolism
|
May 5, 2012
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial
L D Monti, E Setola, P C G Lucotti, et al.
Transplantation Proceedings
|
May 31, 2011
Analysis of the motivation for hematopoietic stem cell donation
M T Aurelio, A Aniasi, S E Haworth, et al.
Human Gene Therapy
|
June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis
P L Poliani, H Brok, R Furlan, et al.
European Journal of Neurology
|
March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study
M S Freedman, G S Francis, E A C M Sanders, et al.
Brain Stimulation
|
December 5, 2013
Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study
F Spagnolo, M A Volonté, M Fichera, et al.
Annals of Hematology
|
January 29, 2017
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma
Novella Pugliese, M Di Perna, I Cozzolino, et al.
Neurology
|
May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MS
M P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology
|
February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a
H Vrenken, M Battaglini, M L de Vos, et al.
Neurology
|
March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS
M Inglese, J H T M van Waesberghe, M Rovaris, et al.
Page
of 70